| Original language | English |
|---|---|
| Pages (from-to) | 146 - 150 |
| Number of pages | 5 |
| Journal | Internal Medicine Journal |
| Volume | 31 |
| Issue number | 3 |
| Publication status | Published - 2001 |
Early Australian experience with infliximab a chimeric antibody against tumour necrosis factor- in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy?
M Mortimore, Peter Raymond Gibson, W S Selby, Graham L Radford-Smith, Timothy H J Florin
Research output: Contribution to journal › Article › Research › peer-review
51
Citations
(Scopus)